AgomAb Therapeutics NV（AGMB）内部人交易：高管与董事近期交易
过去 18 个月，共有 3 位内部人为 AgomAb Therapeutics NV（AGMB）报告了 8 笔 Form 4 交易（最近一笔 2026-10-09）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-09 | Epstein David R | 董事 | 买入 | 5,000 | $44,500 |
| 2026-10-07 | Epstein David R | 董事 | 买入 | 5,000 | $42,850 |
| 2026-10-07 | Kemula Pierre Thadee Victor | Chief Financial Officer | 买入 | 3,000 | $26,010 |
| 2026-10-07 | Knotnerus Tim Jasper | Chief Executive Officer | 买入 | 6,000 | $50,880 |
| 2026-10-07 | Epstein David R | 董事 | 买入 | 5,000 | $43,500 |
| 2026-10-07 | Kemula Pierre Thadee Victor | Chief Financial Officer | 买入 | 5,000 | $42,850 |
| 2026-10-07 | Knotnerus Tim Jasper | Chief Executive Officer | 买入 | 5,000 | $43,500 |
| 2026-10-07 | Kemula Pierre Thadee Victor | Chief Financial Officer | 买入 | 2,000 | $17,080 |
来源：SEC Form 4 申报文件 · 截至 2026-10-09